DNAPrint Genomics, Inc.

$2e-05 USD

$0 (0.0%)

Volume: 331.5K
Average Volume: 27
Market Capitalization: $12.89K
P/E Ratio: 0.00
Dividend Yield: 0.00%
Price Target

Year High: $0.00
Year Low: $0.00
Day High: —
Day Low: —
Payout Ratio: $0.00
Current Ratio: $0.64

Industry, Sector & symbol

Stock Exchange	OTC
CEO	Jatin Patel
Industry	Biotechnology
Sector	Healthcare
Current Symbol	DNAG
CUSIP	23324Q202
CIK	None
Web	http://www.dnaprint.com
Phone	None
Currency	USD
Employees	24
Country	US

Liquidity

Debt-to-Equity Ratio	-1.96
Payout Ratio	0.00
Current Ratio	0.64
Quick Ratio	0.63
Cash Ratio	0.04

Sales & Book Value

Annual Sales	$2.43M
Price / Sales	0.01
Cash Flow	-0.02
Price / Cash Flow	0.00
Price / Book	0.00

Price Target and Rating

Average Stock Price Forecast
High Stock Price Forecast
Low Stock Price Forecast
Forecast Upside/Downside	%
Consensus Rating	N/A
Rating Score(0-5)	0
Research Coverage	0 Analysts

Profitability

EPS (Most Recent Fiscal Year)	-$0.03
Trailing P/E Ratio	0.00
PEG Ratio	0.00
P/E Growth	0.00
Net Income	-$12.35M
Net Margin	-507.54%
Pretax Margin	0.00%
Return on Equity	316.59%
Return on Assets	-120.24%

Financials Score

AltmanZ Score	-30.04
Piotroski Score	3.00
Working Capital	-9.35M
Total Assets	3.11M
Ebit	-5.91M
Market Cap	12.89K
Total Liabilities	11.5M

Poll Results

About DNAPrint Genomics, Inc. (OTC:DNAG) Stock

DNAPrint Genomics, Inc. focuses on pioneering and distributing genetic analysis solutions and services. Their product portfolio includes AncestryByDNA, a comprehensive chromosomal assay for tracing genetic lineage, and EurasianDNA, designed to identify specific European ancestral subdivisions. They also offer EuropeanDNA, which outlines an individual's fundamental continental European heritage. In forensic science, DNAWitness assists in determining genetic background from crime scene samples, while RETINOME is utilized by detectives to construct physical traits, such as eye color, from DNA evidence or human remains. Furthermore, the company provides the GenomeLab SNPstream Genotyping System, recognized for its high genotyping throughput, multiplexing capabilities, and efficient reagent usa ... ge. DNAPrint Genomics caters to diverse clients in fields like forensic investigation, genealogical exploration, consumer products, and pharmaceutical research. Originally incorporated in 1983 as Lexington Energy, Inc., the company operates from Sarasota, Florida, with an international presence through a subsidiary in Leverkusen, Germany.

Frequently Asked Questions

What is the current DNAPrint Genomics, Inc. (DNAG) stock price?: DNAPrint Genomics, Inc.(OTC:DNAG) stock price is $2e-05 in the last trading session. During the trading session, DNAG stock reached the peak price of $0.00002 while $0.000001 was the lowest point it dropped to. The percentage change in DNAG stock occurred in the recent session was 0.0% while the dollar amount for the price change in DNAG stock was $0.
DNAG's industry and sector of operation?: The OTC listed DNAG is part of Biotechnology industry that operates in the broader Healthcare sector.
Who are the executives of DNAG?: Hector de Jesus Ruiz | Executive Officer
Laurence A. Rubin | Executive Officer
Naz Jiwani | Executive Officer
Lisa Tandy Herren | Executive Officer
Pauline Gula | Executive Officer
How many employees does DNAG have?: Number of DNAG employees currently stands at 24. DNAG operates from 1621 West University Parkway, Sarasota, FL None, US.

Link for DNAG official website?: Official Website of DNAG is: http://www.dnaprint.com
How do I contact DNAG?: DNAG could be contacted at phone #None and can also be accessed through its website. DNAG operates from 1621 West University Parkway, Sarasota, FL None, US.
How many shares of DNAG are traded daily?: The average number of DNAG shares traded daily for last 3 months was 27.
What is the market cap of DNAG currently?: The market value of DNAG currently stands at $12.89K with its latest stock price at $2e-05